Press Releases

Our latest happenings and recent highlights.

For media inquiries, please contact: ken.harris@omniabio.com Phone: +1-323-420-7766 (cell)

Press Releases

Featured

LineaBio submits Drug Master File for Linea 1 GMP iPSC line to U.S. Food and Drug Administration

November 20, 2024 (Toronto, Ontario) – LineaBio, a cell line company, today announced it has submitted a Type II Drug Master File (DMF) to the U.S. Food and Drug Administration (FDA) for its flagship unmodified, off-the-shelf, Good Manufacturing Practices (GMP)-compliant induced pluripotent stem cell (iPSC) line, Linea 1.LineaBio was launched in...

Press Releases

OmniaBio celebrates the beginning of construction

OmniaBio, CCRM and Stakeholders Celebrate Commencement of Construction of Hamilton Biomanufacturing Facility...

Press Releases

Ngen supports commercial scale manufacturing of cell and gene therapies in Canada

Next Generation Manufacturing Canada (NGen), the industry-led organization behind Canada’s Global Innovation Cluster for Advanced Manufacturing...

Press Releases

OmniaBio Inc. announces private investor

OmniaBio Inc., a subsidiary of CCRM, has executed a strategic agreement with Medipost, a global leader in stem cell therapeutics...

Press Releases

Funding from Ontario Government for OmniaBio

OmniaBio Inc., a subsidiary of CCRM, is the first project to be funded under the Invest Ontario Fund. Subject to reaching a definitive agreement, OmniaBio Inc...

Press Releases

Invest Ontario supports new biomanufacturing facility in Hamilton

Invest Ontario is supporting OmniaBio Inc. in launching a new biomanufacturing facility that will catalyze Ontario life sciences jobs and innovation...